Medicaments Containing Hormones or Steroids Used as Hormones but not Antibiotics, in Measured Doses
Código 300439 (Harmonized System 2012 by 6 digits)
Exchange by Territory
#permalink to sectionInternational Purchases
#permalink to sectionDenmark: US$221M, Main Commercial Origin (2024)
The countries with the most international sales to Mexico in 2024 were Denmark (US$221M), United States (US$145M), Germany (US$51.9M), France (US$46.8M), and Italy (US$44.2M).
Specialization
#permalink to sectionSpecialization by State
#permalink to sectionThe RCA-Complexity diagram compares the Revelead Comparative Advantages of states in Medicaments Containing Hormones or Steroids Used as Hormones but not Antibiotics, in Measured Doses and the Economic Complexity Index of each state.
RCA values greater than 1 indicate that the state has comparative advantages in Medicaments Containing Hormones or Steroids Used as Hormones but not Antibiotics, in Measured Doses. On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.
Global Market
#permalink to sectionOrigins and Trade Destinations
#permalink to section- 0.15%, Mexican share in global exports - 2022
- 0.7%, Mexican share in global imports - 2022
The visualizations show the global market for Medicaments Containing Hormones or Steroids Used as Hormones but not Antibiotics, in Measured Doses. In both charts, Mexico stands out in order to identify its participation in the export and import market.
In 2022, the main exporting countries of Medicaments Containing Hormones or Steroids Used as Hormones but not Antibiotics, in Measured Doses were N/A. In the same year, the main importing countries for Medicaments Containing Hormones or Steroids Used as Hormones but not Antibiotics, in Measured Doses were United States (US$11.7B), Switzerland (US$3.72B), and Italy (US$2.48B).